)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
DarioHealth
DarioHealth (DRIO) investor relations material
DarioHealth Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Nov, 2026
Executive summary
Q3 revenue rose 6.1% YoY to $5.311M; operating expenses fell 10% and operating loss improved 15%.
Commercial momentum included new health-plan agreements, account expansions, Dario Women and Dario Sleep launches, and broader DarioIQ deployment.
Financial highlights
Q3 revenue was $5.311M versus $5.007M; 9M revenue was $16.071M versus $17.128M, reflecting non-recurring prior-year pharmaceutical revenue.
Q3 operating expenses were $11.2M; operating loss was $8.045M versus $9.484M, and net loss was $8.849M versus $10.5M.
9M operating expenses fell 17% to $31.4M; operating loss improved 22% to $21.833M and net loss improved to $25.022M.
Adjusted Q3 operating loss was $5.316M versus $5.987M; 9M adjusted loss was $15.991M versus $18.162M.
Q3 gross profit was $3.145M; 9M gross profit was $9.538M, including a $448K tariff-refund benefit in cost of revenues.
Outlook and guidance
Contracted and late-stage ARR totaled $13.1M, with more than 80% tied to multi-condition opportunities; management expects gradual conversion from late 2026, mainly in 2027 and continuing into 2028.
Management expects revenue acceleration in 2027, with analyst consensus aligned to its expectations; it sees a path to break-even in 2028.
A Fortune 50 employer selected the integrated cardiometabolic platform for 100,000+ eligible employees, with commercial launch expected in H1 2027.
Expanded provider-backed women’s health and sleep offerings were expected to begin contributing in Q4 2026; the New Jersey plan and expanded Dario Women offering are expected to contribute in 2027.
Cash and short-term deposits were expected to support operations for at least 12 months from issuance of the interim statements; longer-term funding needs remain uncertain.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from DarioHealth
- Multi-condition care and provider expansion underpin $13.1M in ARR opportunities.DRIO
Investor presentation - Multi-condition care and AI underpin expansion, 80% non-GAAP B2B2C gross margin, and ARR growth.DRIOCorporate presentation
- Gross margin rose to 62% and net loss improved 39% as ARR, cash, and commercial wins increased.DRIOQ2 2026
- AI-driven multi-condition platform delivers clinical results, high retention, and rapid growth.DRIOCorporate presentation
- Q1 2026 revenue rose to $5.6M, costs fell, but liquidity concerns remain despite strong pipeline.DRIOQ1 2026
- Multi-condition digital health platform delivers strong growth, clinical outcomes, and high retention.DRIOCorporate presentation
- AI-driven, multi-condition platform achieves clinical validation, strong growth, and high client retention.DRIOCorporate presentation
- Registering up to $100M in securities to support growth and innovation in digital health.DRIORegistration filing
- Record new business and margin gains set the stage for accelerated, ARR-driven growth by 2027.DRIOQ4 2025
Next DarioHealth earnings date
Q4 202618 Mar, 2027
DarioHealth
Next DarioHealth earnings date
Q4 202618 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. It offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.